Cibinqo is a medicine used to treat adults and adolescents from 12 years of age with moderate to severe atopic dermatitis (also known as eczema, when the skin is itchy, red and dry). It is used in patients for whom treatment applied directly to the skin cannot be used or is not sufficient. Cibinqo contains the active substance abrocitinib.
Therapeutic Indication
### Therapeutic indication Cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy.
Therapeutic Area (MeSH)
ATC Code
D11AH08
ATC Item
abrocitinib
Pharmacotherapeutic Group
Other dermatological preparations
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| abrocitinib | N/A | 阿布昔替尼 |
EMA Name
Cibinqo
Medicine Name
Cibinqo
Aliases
N/A
